Desq Long
Sign in

Company

ADARx Pharmaceuticals, Inc.

ADRX · CIK 0001802369

Sign in to watch
SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 10,690,530 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 2,000,962 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 769,601 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 564,187 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 7,127,019 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,333,975 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 513,067 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 256,448 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 10,690,530 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 2,000,962 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 769,601 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 564,187 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 7,127,019 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,333,975 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 513,067 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 256,448 shares; price not stated (see filing).

Reporting Person GORDON CARL L · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 7,127,019 shares; price not stated (see filing).

Reporting Person Chimovits Erez · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,333,975 shares; price not stated (see filing).

Reporting Person Chimovits Erez · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 513,067 shares; price not stated (see filing).

Reporting Person Chimovits Erez · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 256,448 shares; price not stated (see filing).

Reporting Person Chimovits Erez · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →

SEC FORM 4CLUSTER · 5 INSIDERS
$87,745,772.00

ADARx Pharmaceuticals, Inc. (ADRX)

Purchase of 5,161,516 shares across 5 reporting persons.

Transaction Code P · Reporting Persons 5

  • ORBIMED ADVISORS LLCPurchase of 300,249 shares at $17.00 per share.$5,104,233.00
  • ORBIMED ADVISORS LLCPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
  • ORBIMED ADVISORS LLCPurchase of 588,235 shares at $17.00 per share.$9,999,995.00
  • GORDON CARL LPurchase of 300,249 shares at $17.00 per share.$5,104,233.00
  • GORDON CARL LPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
  • GORDON CARL LPurchase of 588,235 shares at $17.00 per share.$9,999,995.00
  • Chimovits ErezPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
  • George SimeonPurchase of 592,593 shares at $17.00 per share.$10,074,081.00
  • George SimeonPurchase of 414,814 shares at $17 per share.$7,051,838.00
  • George SimeonPurchase of 592,593 shares at $17 per share.$10,074,081.00
  • SR ONE CAPITAL MANAGEMENT, LLCPurchase of 592,593 shares at $17.00 per share.$10,074,081.00
  • SR ONE CAPITAL MANAGEMENT, LLCPurchase of 414,814 shares at $17 per share.$7,051,838.00
  • SR ONE CAPITAL MANAGEMENT, LLCPurchase of 592,593 shares at $17 per share.$10,074,081.00

Surfaced by rule: 5 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →

Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

Permalink →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 3,334,938 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,113,666 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 512,897 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,538,691 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,667,468 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 169,001 shares; price not stated (see filing).

Reporting Person George Simeon · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 3,334,938 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,113,666 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 512,897 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,538,691 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,667,468 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 169,001 shares; price not stated (see filing).

Reporting Person SR ONE CAPITAL MANAGEMENT, LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 8,908,775 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,667,469 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 513,067 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 153,868 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 307,738 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 307,738 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →